alli®愛纖伴®減重計劃
alli®愛纖伴®是首個及唯一美國FDA認可及香港衞生署註冊無須醫生處方減重輔助產品。
alli®愛纖伴®及其減重計劃比單靠節食可多減50 (1-3)
1. Rossner SM et al. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obes Res 2000; 8(1): 49-61.
2. Hauptman J et al. Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med 2000; 9: 160-167.
3. Anderson JW et al. Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial. Ann Pharmacother 2006; 40: 1717-1723.